INS and Parkinson disease: Besides its well-established role in AD, emerging evidence suggests insulin resistance also occurring in the brain of PD patients pointing to impaired brain insulin signaling as a potential contributing factor to the pathological defects of PD (Athauda and Foltynie, 2016a).